These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1048 related articles for article (PubMed ID: 32252591)

  • 1. COVID-19 and the Heart.
    Akhmerov A; Marbán E
    Circ Res; 2020 May; 126(10):1443-1455. PubMed ID: 32252591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus disease 2019 and the cardiovascular system: Impacts and implications.
    Gupta MD; Girish MP; Yadav G; Shankar A; Yadav R
    Indian Heart J; 2020; 72(1):1-6. PubMed ID: 32423554
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 and Cardiovascular Disease.
    Clerkin KJ; Fried JA; Raikhelkar J; Sayer G; Griffin JM; Masoumi A; Jain SS; Burkhoff D; Kumaraiah D; Rabbani L; Schwartz A; Uriel N
    Circulation; 2020 May; 141(20):1648-1655. PubMed ID: 32200663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.
    Hendren NS; Drazner MH; Bozkurt B; Cooper LT
    Circulation; 2020 Jun; 141(23):1903-1914. PubMed ID: 32297796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current data on the cardiovascular effects of COVID-19.
    Vlachakis PK; Tentolouris A; Tousoulis D; Tentolouris N
    Hellenic J Cardiol; 2020; 61(1):46-48. PubMed ID: 32315757
    [No Abstract]   [Full Text] [Related]  

  • 6. SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart.
    Dhakal BP; Sweitzer NK; Indik JH; Acharya D; William P
    Heart Lung Circ; 2020 Jul; 29(7):973-987. PubMed ID: 32601020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?
    Huang Y; Xie C; Chen X; Hong Q; Huang H
    Pharmacol Res; 2020 Sep; 159():104959. PubMed ID: 32505834
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 and the Heart.
    Strabelli TMV; Uip DE
    Arq Bras Cardiol; 2020 Apr; 114(4):598-600. PubMed ID: 32236325
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 and the cardiovascular system.
    Zheng YY; Ma YT; Zhang JY; Xie X
    Nat Rev Cardiol; 2020 May; 17(5):259-260. PubMed ID: 32139904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male predisposition to severe COVID-19: Review of evidence and potential therapeutic prospects.
    Acheampong DO; Barffour IK; Boye A; Aninagyei E; Ocansey S; Morna MT
    Biomed Pharmacother; 2020 Nov; 131():110748. PubMed ID: 33152916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review.
    Ingraham NE; Barakat AG; Reilkoff R; Bezdicek T; Schacker T; Chipman JG; Tignanelli CJ; Puskarich MA
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32341103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019.
    Geng YJ; Wei ZY; Qian HY; Huang J; Lodato R; Castriotta RJ
    Cardiovasc Pathol; 2020; 47():107228. PubMed ID: 32375085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis.
    Steenblock C; Todorov V; Kanczkowski W; Eisenhofer G; Schedl A; Wong ML; Licinio J; Bauer M; Young AH; Gainetdinov RR; Bornstein SR
    Mol Psychiatry; 2020 Aug; 25(8):1611-1617. PubMed ID: 32382135
    [No Abstract]   [Full Text] [Related]  

  • 14. Impaired microcirculation function in COVID-19 and implications for potential therapies.
    Gąsecka A; Filipiak KJ; Jaguszewski MJ
    Cardiol J; 2020; 27(5):485-488. PubMed ID: 33165898
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular disease during the COVID-19 pandemic: Think ahead, protect hearts, reduce mortality.
    Li G; Saguner AM; An J; Ning Y; Day JD; Ding L; Waintraub X; Wang J
    Cardiol J; 2020; 27(5):616-624. PubMed ID: 32789839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [2019 novel coronavirus, angiotensin converting enzyme 2 and cardiovascular drugs].
    Shi HZ; Ma P; Gao FY; Chen GL; Wang YH; Xian XD; Dong ED
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):532-538. PubMed ID: 32166940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2.
    Buckley LF; Cheng JWM; Desai A
    J Cardiovasc Pharmacol; 2020 Jun; 75(6):526-529. PubMed ID: 32301766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science.
    AlGhatrif M; Cingolani O; Lakatta EG
    JAMA Cardiol; 2020 Jul; 5(7):747-748. PubMed ID: 32242886
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 in patients with cardiovascular diseases.
    Hulot JS
    Arch Cardiovasc Dis; 2020 Apr; 113(4):225-226. PubMed ID: 32245656
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 and cardiovascular disease: characteristic features in older patients.
    Boureau AS; de Decker L; Berrut G; Hanon O
    Geriatr Psychol Neuropsychiatr Vieil; 2020 Jun; 18(2):141-148. PubMed ID: 33064080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.